NDC 0143-9679-01 - GLYCOPYRROLATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9679
- Requested NDC
- 0143-9679-01
- Package NDCs from labels
- 0143-9679-01, 0143-9679-10
- Manufacturer
- Henry Schein, Inc.
- Effective date
- 2025-08-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| GLYCOPYRROLATE - Henry Schein, Inc. | Henry Schein, Inc. | 2025-08-18 | HUMAN PRESCRIPTION DRUG LABEL |
| GLYCOPYRROLATE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2025-01-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Glycopyrrolate - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-06-01 | HUMAN PRESCRIPTION DRUG LABEL |
| GLYCOPYRROLATE - General Injectables and Vaccines, Inc. | General Injectables and Vaccines, Inc. | 2022-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| WATER - Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | 2022-03-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9679-01 | Glycopyrrolate | 20 mL in 1 VIAL | INJECTION | 20 | 6 | |
| 0143-9679-10 | Glycopyrrolate | 10 in 1 CARTON | INJECTION | 10 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9679-01 | ML - Milliliter | 0143-9679 | 4b35b7dd-b08e-4a9f-a58e-d86aaaa852f3 | 1 | 2013-08-02 |
| 0143-9679-10 | ML - Milliliter | 0143-9679 | 4e1a21c2-b85c-41a6-a7a3-c0961c32bf05 | 1 | 2013-08-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| GLYCOPYRROLATE | ACTIVE INGREDIENT | V92SO9WP2I | GLYCOPYRROLATE INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 2 | |
| GLYCOPYRRONIUM | ACTIVE MOIETY | A14FB57V1D | GLYCOPYRROLATE INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | GLYCOPYRROLATE INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | GLYCOPYRROLATE INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | Chartwell RX, LLC | 5773cf63-4006-4d8f-b53b-c84bcfe19e4a | 2025-12-10 | Warnings, Adverse reactions | V92SO9WP2I |
| Firstep Firstflush | EYEWASH | Encon Safety Products, Inc. | a44beb26-79ae-98bd-e053-2995a90a9b74 | 2025-12-09 | Warnings | 059QF0KO0R |
| Glycopyrrolate | GLYCOPYRROLATE | Rising Pharma Holdings, Inc. | 58c4cb1f-59b8-4be9-a222-2264ca077d93 | 2025-12-03 | Warnings, Adverse reactions | V92SO9WP2I |
| Thermacare Max Strength Lidocaine | THERMACARE MAX STRENGTH LIDOCAINE | Clarion Brands LLC | 44fed887-d1e0-d205-e063-6294a90ac416 | 2025-12-02 | Warnings | LKG8494WBH |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Solco Healthcare US, LLC | 2972f22e-378c-450b-8869-1354a9bd0ffc | 2025-11-30 | Warnings, Adverse reactions | 1731582 1731590 V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Solco Healthcare US, LLC | 3707f06a-6cba-4f5c-86ab-fb95bc2a933c | 2025-11-30 | Warnings, Adverse reactions | 1731582 1731590 V92SO9WP2I |
| Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Rollon | THERMACARE HEAT THERAPY MAX STRENGTH LIDOCAINE PAIN RELIEF ROLLON | Clarion Brands LLC | 4482d34d-eaca-5522-e063-6394a90a6afb | 2025-11-26 | Warnings | LKG8494WBH |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | 059QF0KO0R |
| Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Gel | THERMACARE HEAT THERAPY MAX STRENGTH LIDOCAINE PAIN RELIEF GEL | Clarion Brands LLC | 445db02a-c8e8-6ebb-e063-6294a90a4301 | 2025-11-24 | Warnings | LKG8494WBH |
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | fd823bef-c14c-4708-a18a-8aaa8470412f | 2025-11-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 3765c251-eb14-d60f-e063-6294a90a6a4d | 2025-11-12 | Warnings | 059QF0KO0R |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37f244fd-c02f-e66a-e063-6394a90aed81 | 2025-11-12 | Warnings | 059QF0KO0R |
| Glycopyrrolate | GLYCOPYRROLATE | ProPharma Distribution | 430635e8-7c9e-77f6-e063-6294a90a4c8a | 2025-11-07 | Warnings, Adverse reactions | 238212 V92SO9WP2I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.